NCT03304678
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Lymphangioleiomyomatosis
Explore clinical trials studying Lymphangioleiomyomatosis. Study availability and eligibility vary by location and protocol.
31 public trials
7 recruiting studies
Lymphangioleiomyomatosis trial results
Completed
Letrozole for Lymphangioleiomyomatosis
NCT01353209
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- University of Miami Miami, Florida, United States
- Emory University School of Medicine Atlanta, Georgia, United States
Completed
Efficacy and Safety of Sirolimus in LAM
NCT00414648
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of California Los Angeles Los Angeles, California, United States
- National Jewish Medical and Research Center Denver, Colorado, United States
- University of Florida, Gainesville Gainesville, Florida, United States
- National Heart, Lung, and Blood Institute Bethesda, Maryland, United States
NCT05323370
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +24 more
- Locations
-
- University hospital Tours, France
NCT03253913
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of Cincinnati Cincinnati, Ohio, United States
NCT03062943
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Pneumology unit Milan, Italy
NCT02325505
- Conditions
- Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +25 more
- Locations
-
- InCor Heart Institute São Paulo, Brazil
- InCor Heart Institute, Research Center São Paulo, Brazil
- InCor Heart Institute São Paulo, Brazil
NCT00366509
- Conditions
- Asthma, Bronchial Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +28 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01059318
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Center for LAM Research and Clinical Care Boston, Massachusetts, United States
- University of Cincinnati, Department of Internal Medicine, Pulmonary, Critical Care & Sleep Medicine, Cincinnati, Ohio, United States
- Novartis Investigative Site Lyon, France
- Novartis Investigative Site Milan, Italy
Completed
Safety of Simvastatin in LAM and TSC
NCT02061397
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +24 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States